HUMAN AND MOUSE-LIVER COUMARIN 7-HYDROXYLASES DO NOT METABOLIZE WARFARIN INVITRO

被引:6
作者
HONKAKOSKI, P
ARVELA, P
JUVONEN, R
LANG, MA
KAIRALUOMA, M
PELKONEN, O
机构
[1] UNIV OULU,DEPT PHARMACOL & TOXICOL,SF-90220 OULU,FINLAND
[2] OULU UNIV,CENT HOSP,DEPT SURG,SF-90220 OULU,FINLAND
[3] UNIV KUOPIO,DEPT PHARMACOL & TOXICOL,SF-70211 KUOPIO,FINLAND
关键词
WARFARIN; COUMARIN; HYDROXYLATION; P450; 2A6; 2A-5; DRUG METABOLISM;
D O I
10.1111/j.1365-2125.1992.tb04042.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The contribution of human P450 2A6 and mouse P450 2a-5 isoenzymes, both highly active in coumarin 7-hydroxylation, to the metabolism of warfarin was studied in several in vitro systems with human and mouse liver preparations. 2 The reconstituted P450 2a-5 purified from DBA/2 mouse liver did not metabolize warfarin. 3 An anti-P450 2a-5 antibody did not consistently inhibit any of the warfarin biotransformation reactions catalyzed by human or mouse liver microsomes, although coumarin 7-hydroxylation was inhibited by over 90%. 4 In some human microsomal samples, 4- and 8-hydroxylations of warfarin were inhibited to some extent by the anti-P450 2a-5 antibody. 5 Warfarin (< 1 mM) did not inhibit coumarin 7-hydroxylation by human or mouse liver microsomes in vitro. 6 We conclude that mouse and human coumarin 7-hydroxylases do not oxidise warfarin.
引用
收藏
页码:313 / 317
页数:5
相关论文
共 21 条
[1]   SIMPLE AND SENSITIVE ASSAY OF 7-ETHOXYCOUMARIN DEETHYLATION [J].
AITIO, A .
ANALYTICAL BIOCHEMISTRY, 1978, 85 (02) :488-491
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   NOVEL METHOD FOR THE QUANTITATION OF WARFARIN AND ITS METABOLITES IN PLASMA [J].
FASCO, MJ ;
CASHIN, MJ ;
KAMINSKY, LS .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1979, 2 (04) :565-575
[4]   MOUSE-LIVER PHENOBARBITAL-INDUCIBLE P450 SYSTEM - PURIFICATION, CHARACTERIZATION, AND DIFFERENTIAL INDUCIBILITY OF 4 CYTOCHROME-P450 ISOZYMES FROM THE D2 MOUSE [J].
HONKAKOSKI, P ;
LANG, MA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 273 (01) :42-57
[5]  
JUVONEN R, 1990, DRUG METABOLIZING EN, P131
[6]   PYRAZOLE AS A MODIFIER OF LIVER MICROSOMAL MONOOXYGENASE IN DBA/2N AND AKR/J MICE [J].
JUVONEN, RO ;
AUTIO, S ;
LANG, MA .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (22) :3993-3997
[7]   PURIFICATION AND CHARACTERIZATION OF A LIVER MICROSOMAL CYTOCHROME-P-450 ISOENZYME WITH A HIGH-AFFINITY AND METABOLIC CAPACITY FOR COUMARIN FROM PYRAZOLE-TREATED D2 MICE [J].
JUVONEN, RO ;
SHKUMATOV, VM ;
LANG, MA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 171 (1-2) :205-211
[8]   COMPOSITION OF CYTOCHROME-P-450 ISOZYMES FROM HEPATIC MICROSOMES OF C57BL/6 AND DBA/2 MICE ASSESSED BY WARFARIN METABOLISM, IMMUNOINHIBITION, AND IMMUNOELECTROPHORESIS WITH ANTI-(RAT CYTOCHROME-P-450) [J].
KAMINSKY, LS ;
DANNAN, GA ;
GUENGERICH, FP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 141 (01) :141-148
[9]   INDUCTION OF LIVER CYTOCHROME-P-450 IN MICE BY WARFARIN - COMPARISON OF WARFARIN-INDUCED, PHENOBARBITONE-INDUCED, AND COBALT-INDUCED HEPATIC-MICROSOMAL PROTEIN-PATTERNS BY PAGE AFTER PARTIAL-PURIFICATION ON OCTYL-SEPHAROSE CL-4B [J].
KLING, L ;
LEGRUM, W ;
NETTER, KJ .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :85-91
[10]  
KLING L, 1981, NAUNYNSCHMIEDEBE SR6, V316